Lauren Warneke
Nurse Practitioner · Council Bluffs, IANPI 1689245250
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,264 of the $2,818 with a category attached, or 80.3%. 19 manufacturers reported payments, led by Abbott at 33.2% of the total. Reporting peaked in 2023 at $818 and has fallen 67.9% since, to $263 in 2025. Among nurse practitioner clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 94 payments — averaging $29.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$935
- Medtronic$407
- Amgen$298
- Novartis$216
- Edwards Lifesciences$183
- Boehringer Ingelheim$161
- plus $619 from 13 others
What the payments were for
- Travel & lodging$55420%
- Food & beverage$2,26480%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 15 | $935 |
| Medtronic | 4 | $407 |
| Amgen | 10 | $298 |
| Novartis | 16 | $216 |
| Edwards Lifesciences | 3 | $183 |
| Boehringer Ingelheim | 10 | $161 |
| Merck | 7 | $102 |
| Johnson & Johnson | 7 | $102 |
| Pfizer | 5 | $83 |
| Janssen Scientific Affairs, LLC | 1 | $81 |
| Bayer | 3 | $57 |
| Lexicon Pharmaceuticals, Inc. | 3 | $46 |
| Scpharmaceuticals Inc. | 2 | $39 |
| AstraZeneca | 2 | $33 |
| Impulse Dynamics (USA) Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $15 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $14 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CARDIOMEMS$545
- LINQ II$334
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$194
- Repatha$148
- PASCAL$134
How this compares
$2,818 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 174 | $198,402 |
| EliquisApixaban | 147 | $127,925 |
| FarxigaDapagliflozin Propanediol | 98 | $98,658 |
| JardianceEmpagliflozin | 46 | $50,961 |
| Torsemide | 148 | $4,091 |
| Metoprolol Succinate | 243 | $3,511 |
| Potassium Chloride | 85 | $1,843 |
| Bumetanide | 35 | $1,582 |
| Spironolactone | 218 | $1,563 |
| Atorvastatin Calcium | 142 | $987 |
| Furosemide | 168 | $792 |
| Ezetimibe | 23 | $767 |
| Carvedilol | 62 | $736 |
| Digoxin | 17 | $651 |
| Amiodarone Hcl | 33 | $437 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $216 | $198,402174 claims |
| PfizerEliquis | $83 | $127,925147 claims |
| AstraZenecaFarxiga | $33 | $98,65898 claims |
| Boehringer IngelheimJardiance | $161 | $50,96146 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,346 nurse practitioner providers in Iowa.
Other nurse practitioner in Council Bluffs
- Marcella SorrellCouncil Bluffs$7K
- Tara SandsCouncil Bluffs$4K
- Nicole MorganDes Moines$106K
- Julie CoffeyIowa City$31K
- Mary JohnsonDavenport$30K
- Megan Hart FernandezCedar Rapids$19K
- Carla HuberCedar Rapids$18K
- Beth ChiaWest Des Moines$15K
- Margaret KinneyRed Oak$13K
- Abbey ModlinDes Moines$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.